type here...

CATEGORIES

Press Release

LATEST

1...101112Page 12 of 12

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Uqora Develops the First Non-Antibiotic Treatment Option for UTIs

Medika Life -
The new drug program aims to decrease the amount of UTIs that would otherwise require antibiotic intervention.

Impact of COVID-19 on the Respiratory Device Accessories Market

Medika Life -
This report is built to visualize quantitative market trends within Anesthesia and Respiratory Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Respiratory Devices

WMCHealth Launches Post-COVID-19 Recovery Program

Medika Life -
An increasing number of people who became ill from the coronavirus have physical, mental and emotional symptoms that linger well after an initial infection

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories